2 weeks Ago By Defense World Staff
Brown Shipley& Co Ltd increased its stake in shares of Agilent Technologies, Inc. ( NYSE:A – Free Report ) by 1.3% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission.
The fund owned 31,017 shares of the medical research company’s stock after buying an additional 385 shares during the quarter. Agilent Technologies comprises about 1.8% of Brown Shipley& Co Ltd’s holdings, making the stock its 19th largest position.
Brown Shipley& Co Ltd’s holdings in Agilent Technologies were worth $4,021,000 as of its most recent filing with the Securities & Exchange Commission. Several other institutional investors have also recently added to or reduced their stakes in the stock. Gilbert & Cook Inc.
lifted its holdings in shares of Agilent Technologies by 12.5% in the 4th quarter. Gilbert & Cook Inc.
now owns 2,872 shares of the medical research company’s stock valued at $399,000 after buying an additional 320 shares during the period. Cambridge Investment Research Advisors Inc. boosted its holdings in shares of Agilent Technologies by 6.
8% during the fourth quarter. Cambridge Investment Research Advisors Inc. now owns 12,621 shares of the medical research company’s stock worth $1,755,000 after purchasing an additional 807 shares during the last quarter.
Orion Portfolio Solutions LLC grew its position in shares of Agilent Technologies by 19.2% in the fourth quarter. Orion Portfolio Solutions LLC now owns 11,033 shares of the medical research company’s stock valued at $1,472,000 after purchasing an additional 1,774 shares during the period.
Stifel Financial Corp increased its stake in Agilent Technologies by 9.6% in the fourth quarter. Stifel Financial Corp now owns 131,080 shares of the medical research company’s stock valued at $18,229,000 after purchasing an additional 11,498 shares during the last quarter.
Finally, California State Teachers Retirement System lifted its position in Agilent Technologies by 1.0% during the fourth quarter. California State Teachers Retirement System now owns 469,486 shares of the medical research company’s stock worth $65,273,000 after buying an additional 4,788 shares during the period.
Institutional investors and hedge funds own 87.42% of the company’s stock. Agilent Technologies Trading Up 0.
9 % NYSE A opened at $148.06 on Monday. The company’s fifty day simple moving average is $138.
91 and its 200-day simple moving average is $138.99. The stock has a market cap of $43.
20 billion, a P/E ratio of 35.00, a PEG ratio of 6.48 and a beta of 1.
05. Agilent Technologies, Inc. has a 52 week low of $96.
80 and a 52 week high of $155.35. The company has a current ratio of 1.
78, a quick ratio of 1.37 and a debt-to-equity ratio of 0.36.
Agilent Technologies Dividend Announcement The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 23rd. Shareholders of record on Tuesday, October 1st will be issued a dividend of $0.236 per share.
This represents a $0.94 annualized dividend and a yield of 0.64%.
The ex-dividend date of this dividend is Tuesday, October 1st. Agilent Technologies’s dividend payout ratio is currently 22.22%.
Analyst Upgrades and Downgrades A has been the subject of several recent analyst reports. Barclays lifted their price target on Agilent Technologies from $125.00 to $135.
00 and gave the company an “underweight” rating in a report on Friday, August 23rd. Bank of America increased their target price on Agilent Technologies from $140.00 to $147.
00 and gave the stock a “neutral” rating in a research report on Thursday, August 22nd. Stifel Nicolaus reissued a “buy” rating and set a $151.00 price target on shares of Agilent Technologies in a research report on Monday, August 26th.
UBS Group raised their price objective on Agilent Technologies from $141.00 to $150.00 and gave the stock a “neutral” rating in a report on Thursday, August 22nd.
Finally, Evercore ISI lifted their price objective on Agilent Technologies from $130.00 to $135.00 and gave the company an “in-line” rating in a research note on Thursday, August 22nd.
One research analyst has rated the stock with a sell rating, five have assigned a hold rating and nine have issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $142.
93. Get Our Latest Stock Report on A Insider Activity In other news, CEO Padraig Mcdonnell sold 1,958 shares of Agilent Technologies stock in a transaction that occurred on Friday, July 26th. The stock was sold at an average price of $140.
00, for a total value of $274,120.00. Following the completion of the transaction, the chief executive officer now owns 26,076 shares in the company, valued at approximately $3,650,640.
The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink . In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,958 shares of the stock in a transaction on Friday, July 26th. The shares were sold at an average price of $140.
00, for a total transaction of $274,120.00. Following the sale, the chief executive officer now directly owns 26,076 shares of the company’s stock, valued at $3,650,640.
The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website . Also, SVP Dominique Grau sold 9,990 shares of the firm’s stock in a transaction dated Thursday, September 26th. The stock was sold at an average price of $145.
00, for a total transaction of $1,448,550.00. Following the completion of the transaction, the senior vice president now owns 40,011 shares in the company, valued at $5,801,595.
The disclosure for this sale can be found here . In the last 90 days, insiders have sold 13,906 shares of company stock worth $2,006,580. 0.
33% of the stock is currently owned by corporate insiders. About Agilent Technologies ( Free Report ) Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab.
The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. Further Reading Five stocks we like better than Agilent Technologies Are Penny Stocks a Good Fit for Your Portfolio? 3 Bargain Stocks Under $20 With Major Growth Potential Buy P&G Now, Before It Sets A New All-Time High Top 5 ETFs to Own Now and Into 2025 The How and Why of Investing in Gold Stocks Watch These 3 Former Short-Squeeze Stocks for a Big Rally Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc.
( NYSE:A – Free Report ). Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter .
.
